Cantor Fitzgerald initiated coverage on Vanda Pharma with a new price target

7/11/24 7:49:37 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Cantor Fitzgerald initiated coverage of Vanda Pharma with a rating of Overweight and set a new price target of $11.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$VNDA

Date	Price Target	Rating	Analyst
10/31/2024	$18.00	Buy	H.C. Wainwright
7/11/2024	$11.00	Overweight	Cantor Fitzgerald
2/25/2022	$24.00 → $12.00	Buy → Hold	Jefferies